The molecular basis of multidrug resistance in cancer: The early years of P-glycoprotein research
Abstract
The discovery and characterization of P-glycoprotein, an energy-dependent multidrug efflux pump, as a mechanism of multidrug resistance in cancer is generally accepted as a significant contribution to the ongoing effort to end death and suffering from this disease. The historical reflections of Victor Ling and Michael Gottesman concerning the early years of this research highlight the important contributions of the multidisciplinary teams involved in these studies, and illustrate how technological developments in biochemistry and molecular and cell biology enabled this discovery.
Keywords: Multidrug resistance, P-glycoprotein, MDR1, Somatic cell genetics, Transport, Chemotherapy
To access this article, please choose from the options below
PII: S0014-5793(05)01543-7
doi:10.1016/j.febslet.2005.12.060
© 2005 Federation of European Biochemical Societies. Published by Elsevier BV. All rights reserved.
